By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Syrian Arab News Agency (SANA)
  • Latest News
  • Syria
  • Middle East
  • Economy
  • Politics
  • Sport
  • International
Reading: Australian startup advances protein-tracking technology for drug discovery
  • AR
  • TR
  • FR
  • ES
  • KU
  • Culture
  • Video
  • Photos
  • Miscellaneous
Syrian Arab News Agency (SANA)Syrian Arab News Agency (SANA)
  • Latest News
  • Syria
  • Middle East
  • Economy
  • Politics
  • Sport
  • International
Search
  • Latest News
  • News Categories
    • Politics
    • Culture
    • Video
    • Photos
    • Miscellaneous
  • Provinces
  •  Languages
    • العربية
    • Türkçe
    • Français
    • Español
    • Kurdî
Follow US
Syrian Arab News Agency (SANA) > Latest News > Miscellaneous > Australian startup advances protein-tracking technology for drug discovery

Australian startup advances protein-tracking technology for drug discovery

Published: 2026/10/20 2:32 PM
Updated: 2026/10/20 2:32 PM
Australian startup advances protein-tracking technology for drug discovery
(From left) Professor Frederic Meunier, Dr. Tristan Wallis and Accretion Bio CEO Phillip Craig. Photo: The University of Queensland

Brisbane, Oct. 20 (SANA) Australian biotechnology startup Accretion Bio is preparing to use a University of Queensland-developed platform to advance early-stage drug discovery for Alzheimer’s and Parkinson’s diseases by tracking protein behavior inside living neurons.

The platform, known as NASTIC (Nanoscale Spatiotemporal Indexing Clustering), enables researchers to monitor how individual proteins move, cluster and interact inside living cells and assess how potential drug candidates affect them.

Developed over more than two decades of research at the university’s Queensland Brain Institute, NASTIC has been spun out into Brisbane-based Accretion Bio, with support from the university’s commercialization company UniQuest and backing from venture firm Antler.

Professor Frederic Meunier, who led the research with colleague Dr. Tristan Wallis, said the platform allows scientists to track proteins inside living neurons and observe how potential drug candidates influence their behavior.

Accretion Bio CEO Phillip Craig said the company would work with pharmaceutical and biotechnology partners to apply NASTIC to their research programs while advancing its own drug discovery program focused on neurodegenerative diseases.

The University of Queensland said industry-funded research using the platform was already underway and that it had attracted interest from global pharmaceutical companies. Potential applications could also extend to immunology and oncology, where protein clustering plays a role in cell signaling.

The underlying scientific methodology was described in a paper published in Nature Protocols in August 2025. Accretion Bio is scheduled to present at the Early-Stage Innovation Forum and exhibit in Queensland Startup Alley at AusBiotech 2026 on the Gold Coast from October 21 to 23.

The platform is intended to support early-stage research, but further investigation is needed to establish its contribution to developing effective treatments for Alzheimer’s and Parkinson’s.

R.H/M.F

Israeli occupation forces kill 62 Palestinians in the Gaza Strip
Norway’s King Harald V dies at 89 after 35 years on throne
42 students missing after armed attack on school in Nigeria’s Borno State
Gaza death toll surges to 56,412 amid ongoing Israeli genocide
Former European officials urge EU action against Israeli settlement expansion
  • press
  • Photos
  • Video
  • Miscellaneous
TAGGED:Accretion BioNASTICUniversity of Queensland
Share This Article
Facebook Whatsapp Whatsapp LinkedIn Telegram Copy Link

Editors Choice

U.S. war against Iran has cost $48.3 billion, Pentagon official says

U.S. war against Iran has cost $48.3 billion, Pentagon official says

November 20, 2026
Damascus Opera House celebrates Fairuz's musical legacy in tribute concert

Damascus Opera House celebrates Fairuz’s musical legacy in tribute concert

November 20, 2026
Shelton reaches ATP Finals semifinals after victory over Jodar

Shelton reaches ATP Finals semifinals after victory over Jodar

November 20, 2026
GCC chief calls for stronger Gulf-Mediterranean ties to bolster global security

GCC chief calls for stronger Gulf-Mediterranean ties to bolster global security

November 20, 2026
Syrian Arab News Agency (SANA)

Syrian Arab News Agency – SANA

The official national news agency of Syria, established on June 24, 1965. It is affiliated with the Ministry of Information and headquartered in Damascus.

  • Presidency
  • Politics
  • Syria
  • Economy
  • Health
  • International
  • Education
  • Culture
  • Sport
  • Tour Syria
  • press
  • Photos
  • Video
  • Miscellaneous
© Syrian Arab News Agency. All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?